Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -1.57% | -14.97% | -6.02% |
06-14 | Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform | CI |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.02% | 39.1M | |
-34.27% | 14.75B | |
-54.93% | 2.22B | |
+15.49% | 1.82B | |
-14.07% | 1.43B | |
+21.99% | 1.23B | |
+1.25% | 784M | |
-35.50% | 741M | |
-36.65% | 723M | |
-28.15% | 602M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Transcript : Co-Diagnostics, Inc., Q2 2023 Earnings Call, Aug 10, 2023